Cannabinoid Receptor Signaling 71Deadwyler SA, Hampson RE, Mu J, Whyte A, Childers S (1995) Cannabinoids modulate
voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent
process. J Pharmacol Exp Ther 273:734–743
DerkinderenP,ToutantM,BurgayaF,LeBertM,SicilianoJC,deF,V,GelmanM,GiraultJA
(1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science
273:1719–1722
Derkinderen P, Ledent C, Parmentier M, Girault JA (2001a) Cannabinoids activate p38
mitogen-activatedproteinkinasesthroughCB1receptorsinhippocampus.JNeurochem
77:957–960
Derkinderen P, Toutant M, Kadare G, Ledent C, Parmentier M, Girault JA (2001b) Dual
role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J Biol Chem
276:38289–38296
Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche
J, Girault JA (2003) Regulation of extracellular signal-regulated kinase by cannabinoids
in hippocampus. J Neurosci 23:2371–2382
Derocq JM, Jbilo O, Bouaboula M, Segui M, Clere C, Casellas P (2000) Genomic and func-
tional changes induced by the activation of the peripheral cannabinoid receptor CB2
in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell
differentiation. J Biol Chem 275:15621–15628
Devane WA, Dysarz FA, III, Johnson MR, Melvin LS, Howlett AC (1988) Determination and
characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613
Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR (1999) Cannabimimetic fatty
acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem
6:721–744
Dill JA, Howlett AC (1988) Regulation of adenylate cyclase by chronic exposure to cannabi-
mimetic drugs. J Pharmacol Exp Ther 244:1157–1163
Eisinger DA, Ammer H, Schulz R (2002) Chronic morphine treatment inhibits opioid re-
ceptor desensitization and internalization. J Neurosci 22:10192–10200
Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, Iuvone T
(2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-
induced cytotoxicity. Mechanism and regulation. J Biol Chem 277:50348–50354
Fan F, Tao Q, Abood M, Martin BR (1996) Cannabinoid receptor down-regulation without
alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of
CP 55,940-tolerant mice. Brain Res 706:13–20
Faubert Kaplan BL, Kaminski NE (2003) Cannabinoids inhibit the activation of ERK MAPK
in PMA/Io-stimulated mouse splenocytes. Int Immunopharmacol 3:1503–1510
Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA (1992) Cannabinoid agonists
stimulate both receptor- and non-receptor-mediated signal transduction pathways in
cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol
42:838–845
Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA (1993) Anandamide,
an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid
receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci U S
A 90:7656–7660
Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell
RL (1995) Comparison of the pharmacology and signal transduction of the human
cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443–450
Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC,
Johnson DW, Chaney MO, Koppel GA, Brownstein M (1998) LY320135, a novel cannabi-
noid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of
cAMP accumulation. J Pharmacol Exp Ther 284:291–297
Fimiani C, Liberty T, Aquirre AJ, Amin I, Ali N, Stefano GB (1999a) Opiate, cannabinoid, and
eicosanoid signaling converges on common intracellular pathways nitricoxide coupling.
Prostaglandins Other Lipid Mediat 57:23–34